Related Experiment Videos
[Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues]
Bernard Bannwarth1, Fabienne Péhourcq
1Service de Rhumatologie, Groupe Hospitalier Pellegrin & Laboratoire de Thérapeutique, EA 525, Université Victor Segalen, Bordeaux, France. bernard.bannwarth@u-bordeaux2.fr
Drugs
|February 5, 2004
Summary
Paracetamol (acetaminophen) offers versatile administration routes and linear pharmacokinetics, making it effective for various pain conditions. Dosage guidelines exist for adults and children, with considerations for specific patient groups and drug interactions.
Area of Science:
- Pharmacology and Therapeutics
- Pain Management
- Drug Metabolism and Interactions
Context:
- Paracetamol (acetaminophen) is a widely used analgesic and antipyretic medication.
- Its efficacy is established across diverse acute and chronic pain syndromes.
- Administration routes include oral, intravenous, and rectal, with varying absorption characteristics.
Purpose:
- To review the pharmacokinetic properties of paracetamol.
- To outline optimal dosing strategies for adults and children.
- To discuss its use in specific patient populations and potential drug interactions.
Summary:
- Paracetamol exhibits linear pharmacokinetics at therapeutic doses, independent of dose and consistent with repeated administration.
- Optimal adult dosing is 1g, with a maximum of 4g daily; effervescent formulations enhance absorption.
- It is suitable for the elderly and those with renal insufficiency but contraindicated in hepatic insufficiency; safe in pregnancy and lactation.
- Low protein binding and hepatic metabolism (glucuronide/sulfate conjugation) minimize drug interactions.
- Pediatric dosing requires age-specific adjustments due to pharmacokinetic variability and erratic suppository bioavailability.
Impact:
- Provides evidence-based guidelines for paracetamol use in clinical practice.
- Highlights safety considerations and contraindications for specific patient groups.
- Informs healthcare professionals on optimizing paracetamol therapy for enhanced efficacy and safety.